chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she has Crohns Disease; My dental hygenist mentioned in conversation that she received the Pfe Vaccine in December 2020 and Jan 2021.  She indicated every day since the second dose, she has experience hives that come and go; hives that come and go and which are painful and itchy.; hives that come and go and which are painful and itchy; This is a spontaneous report from a contactable consumer or other non hcp. An adult female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: unknown; Expiration Date: unknown), dose 2 via an unspecified route of administration in Dec 2020 as SINGLE DOSE for COVID-19 immunization.  The patient medical history was not reported. The patient's concomitant medications were not reported. In Jan2021, The patient experienced crohns disease and indicated every day since the second dose, she has experience hives that come and go and which are painful and itchy. The reporter dental hygienist mentioned in conversation that she received the vaccine in December 2020 and Jan 2021. The patient indicated that she has Crohns Disease and thought perhaps it might be related. The patient said has not sought treatment for the hives. The outcome of events was not recovered. Information on the lot/batch number has been requested.
He got his vaccine, he had the localized pain for a day or two.  Then about the 3rd day he noticed the pain was still there and when he holds the phone for a long time talking he starts feeling the pain.  Also when he's laying down on the left arm after a while it starts hurting and he has to turn over to get rid of the pain, and this happens all the time and when he's laying down every night he has the pain.  He cannot hold his phone in his left hand for a long time due to the pain.  The pain is localized around the injection site itself.  He has a friend that is having the exact same symptoms as well.  He has not taken anything for the pain/reaction or called his doctor.   This has been going on for almost 2 months and wonders if he has a blockage in that arm.   This pain wakes him up at night and he has to switch locations in order to get rid of the pain.
Narrative:  COVID infection following COVID vaccine series 02/23, Pfizer, dose #1 03/16, Pfizer, dose #2 12/28 COVID swab, result: detected 12/26 pt cc: dyspnea, sore throat, exposure: unknown
LEFT ARM SWOLLEN, WARM, PAIN 8/10. COULD NOT LIFT FOR 1.5 DAYS Narrative:  Other Relevant History:
Swelling and redness of right foot toes 1-3 at bedtime. Issue resolved on its own overnight.
About 1 1/2 hours after vaccine redness & swelling at site occurred ((R) upper arm) approximately 6 x3 in, no itch, no pain; this lasted about 2 1/2 days; Mom gave BENADRYL x 1 at onset but it made no difference. I saw on D3 & it had about 1x1" firmness, no red. He also had HA, weakness, fatigue & dizziness.
Severe headache followed by neck pain and pain turning head side to side , dizziness , itching a lot followed by rash on back of neck which spread into scalp and down back and towards face . Burning sensation of skin where Itching started and hives appeared with small blister type spots on neck . Took 50mg of Benadryl , reported reaction to work who administered the vaccine and seeing family doctor today for further instructions as symptoms are still present .
tested positive for covid; tingling throat; chest pains; arm soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL PARAESTHESIA (tingling throat), CHEST PAIN (chest pains), COVID-19 (tested positive for covid) and VACCINATION SITE PAIN (arm soreness) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm soreness). On 20-Mar-2021, the patient experienced PHARYNGEAL PARAESTHESIA (tingling throat) and CHEST PAIN (chest pains). On 23-Mar-2021, the patient experienced COVID-19 (tested positive for covid). On 20-Mar-2021, VACCINATION SITE PAIN (arm soreness) had resolved. At the time of the report, PHARYNGEAL PARAESTHESIA (tingling throat) and CHEST PAIN (chest pains) had resolved and COVID-19 (tested positive for covid) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Swollen  nodes in neck 48 hours after the vaccine. It lasted for 7 days.
A report has been received from a pharmacy intern concerning a male child above 10 years (exact age unknown). No information regarding relevant history and concomitant medication was provided. The patient received FLUMIST QUADRIVALENT (intranasal), on 15-Oct-2014. It was reported that FLUMIST QUADRIVALENT was administered to a patient and either all the dose went in one nostril or half the dose went into one nostril on 15-Oct-2014. Action taken with FLUMIST was not applicable. The outcome of the event of partial dose or full dose up one nostril was unknown. The report was considered to be non-serious by the reporter.
This spontaneous case, initially received from other non-health professional on 01-Oct-2018, concerns a 42-year-old, adult female patient. The patient had no relevant medical history. The patient had not received any concomitant medications. On 10-Oct-2018, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: subcutaneous, anatomical location: arm, batch number and expiry date: not reported]. The patient felt that the vaccine was administered in the back of the arm and not in the deltoid region. No adverse events were reported after administration of the vaccine. The reporter assessed this case as non-serious. Follow up received from other non-health professional on 30-Oct-2018: The dose (0.5 ml) of the suspect vaccine was added. The narrative was amended accordingly.
Pallor, chills, fever 100.5. 20 minutes after 1st Temp -99.5. -Student was sent home.
Patient received flu vaccine 10/20/2003 on left deltoid.  Patient complained of itching Monday night and noticed a papule on 10/21/2003.  Complained of severe itching at site.
Extreme pain in arm shortly following the vaccination. Participant states it felt like it had been re-broken. After a day or two she went out to the mini clinic. Nothing was done.
Headaches, fever, body chills, muscle aches, stomach aches, runny nose, coughing, extreme fatigue
First vaccine - COVID arm 5 days after dose, lasting 3-4 days with itching and redness as well as heat at the site Second vaccine - arm soreness several hours after dose, fever and headache 8 hours after dose lasting about 24 hours, armpit lymph node swelling and tenderness/pain lasting 2 days
Fever, erythema multiform and swelling and erythema spreading around injection site. Influenza 0.5 ml once.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 02/27/2021,pfizer,Lot#EN6203 2nd dose: 03/20/2021,Pfizer,Lot# ER8727 Diagnosed covid positive:05/08/21 Exposure:Home Symptoms:SOB,Sinus pressure,headache.
At 11:30 PM on 1/4/2021 I awoke to severe headache, joint, and body aches.  Broke our into a cold sweat and then chills. Became nauseous and extremely dizzy. Was forced to call off from work.  Contacted the occupational health doctor at the facility where I received the vaccine (my employer) and reported my reaction.   Was advised to rest, take pain reliever and report back if symptoms were not gone after 2 days
pt recv 2nd dose of vax on 22MAY97 & the following day pt devel urticaria rash on arms & trunk;
warm to touch at vaccination site; vaccination site redness; vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), LISINOPRIL, BUPROPION, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), ASCORBIC ACID, RETINOL, TOCOPHEROL (OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]), MULTIVITAMIN [VITAMINS NOS] and SIMVASTATIN for an unknown indication, COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site). At the time of the report, VACCINATION SITE ERYTHEMA (vaccination site redness), VACCINATION SITE PRURITUS (vaccination site pruritus) and VACCINATION SITE WARMTH (warm to touch at vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
W/in 10 mins PT had red swollen area right thigh. lindenated (?) lesions (DTaP) as well as on right upper arm (TR) Gave Benadryl 6.25 mg po x 1.
Bullous vesicles 48 hrs post injection at injection site with mild surrounding erythema. Tenderness-txed with Keflex x 10 days.
Chills and insomnia the night after receiving vaccine 11pm to 7am. Then woke very hot with a 100 degree fever, nausea, body aches, headache, fatigue, dizziness. I slept until 2pm & nausea lessened but still had a fever, aches & extreme fatigue. By 2/7 I am still feeling weak & fatigued, no appetite, headache is gone & body aches are less severe. Arm by injection site is still very sore.
Febrile seizure - increased seizure-like activity. Pt has dx of seizures. Phenobarbital dose increased per neurologist order.
Two days post 3rd vax, pt began to have arthralgias of hands, elbows, shoulders and neck. Also reports fatigue and short term memory loss. Symptoms persist.
One week after my second COVID-19 vaccine I began to have sciatica type nerve pain in my right leg. Six years ago I had hemi-laminectomy back surgery for a pinched nerve from spinal stenosis in the L3-L5 area due to excruciating nerve pain in my left leg. After the surgery, I was fine for 6 years. In March of this year, after my second shot, I began to get numbness and tingling in my right foot and searing nerve pain on the outer side of my lower right leg. I had an MRI that was evaluated by 2 surgeons. Although there are issues, neither one saw large changes or specific locations of impingement to warrant surgery at this time. But they cannot give a definitive reason for the inflamed nerve. I received an extremely
pt woke up in AM of 25MAR98 w/red area @ inj site size of silver dollar;area did get sl redder during the day;pt put ice on area of inj in evening;in AM of 26MAR98 area of redness approx 2 1/2inches in diameter;put warm compress on area
Sore throat; Muscle ache; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) and MYALGIA (Muscle ache) in a 72-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     Concurrent medical conditions included Blood pressure high (treated), Premature ventricular contractions (treated) and Allergy. Concomitant products included VERAPAMIL from 10-Sep-2020 to an unknown date, ATORVASTATIN from 10-Sep-2020 to an unknown date and HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (HYZAAR) from 09-Jan-2023 to an unknown date for an unknown indication.    On 12-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Feb-2023 at 7:00 AM, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and MYALGIA (Muscle ache). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 09-Feb-2023 to 14-Feb-2023 for COVID-19 treatment, at an unspecified dose and frequency. On 12-Feb-2023, OROPHARYNGEAL PAIN (Sore throat) and MYALGIA (Muscle ache) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Patient's race was reported. Patient took first dose of Moderna with batch number 012L20A on 12-Jan-2021 and location of injection was left arm. Patient took second dose of Moderna with batch number 010M20A on 09-Feb-2021 and location of injection was left arm. Patient took third dose of Moderna with batch number 035C21A on 28-OCT-2021 and location of injection was left arm. Patient took fourth dose of Moderna with batch number 033C21-2A on 20-MAR-2022 and location of injection was left arm.
sinus problem; migraine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on 27Jan2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included laxatives. On an unspecified date, the patient experienced sinus problem and migraine. Caller stated that the patient had received the first dose of the bnt162b2 vaccine on 27Jan2021. The second dose was re-scheduled for tomorrow (day after reporting). Caller had some unresolved underlying conditions. Caller was having some digestive issues since last Sunday. It was not accompanied by fever. She was feeling better on the day of reporting. She believed this was the effect of the candy she ate. She also took some laxatives which lead to her having diarrhea. She mentioned she hadn't had diarrhea for years. She had a sinus problem and a migraine post vaccination. Caller wanted to know if she was eligible to receive the second dose of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had severe palpitations that began 3 to 4 days after the vaccine.  It  felt like I was being stabbed in my chest with radiation into my neck. This lasted 2 to 3 weeks. I did go to the ED on 01/05/2021.  I saw a cardiologist on 01/13/2021. I did get  Dose 2 of the vaccine with the same symptoms but they were milder. I was put on an Event Monitor the week after Dose 2
5 minutes after he got the shot my son started convulsing and losing consciousness. After about 30 seconds of this he started to vomit, he continued to vomit off an on for the next few minutes.
Fatigue, muscle aches, chills started around 6am. Fever started around 4pm (101.8 highest)
Accelerated palpitations, dizziness and tiredness after the first dose, this occurs occasionally even when at rest, with the third dose I had recurring swelling of the lymph nodes on the right side, neck, breast, armpit for three days
Report 2001018906-1 described injection site hot to touch in a 4 year old male who received Infanrix. The vaccinee was allergic to sulfa. He had no medical history and received no concomitant medications. On 07/31/2001, the vaccinee received his fourth left thigh dose of Infanrix. Subsequently, he developed localized swelling at the injection site. Additionally, the injection site was hot to touch. As of 08/02/2001, the adverse events had resolved.
Patient was accidentally given vaccine from vial that was left sitting out overnight and had been punctured over 12 hours earlier.
swelling & redness w/in 1 hr of inj; pt was seen by MD 14MAR95 was given 1 dose DPh;
Vaccine administration error related to temperature excursion from recommended storage temperature, not known by this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine.)
received Pfizer FE3590 1st dose in my right arm. almost immediately i noticed a weird taste in my mouth, if i had to describe it. i would say it tasted like metal? almost like i had a coin in my mouth. it was very strong, and lasted for 2days. in addition, i also had off balance and a weird feeling when i left 30mins later and tried to drive. i was "off" feeling and had like a brain fog if i had to describe it.
Within 5 minutes of receiving Td vaccine patient with numbness/tingling of fingers followed by several days of prickling sensation to thumb, then continued numbness. 5 days later minimal thumb pain. Pt seeing neurologist.
32 week pregnant patient inadvertently received two doses of Adacel, no advesre event; 32 week pregnant patient inadvertently received two doses of Adacel, no advesre event; Initial information received on 22-Oct-2019 regarding an unsolicited valid non-serious case from a nurse.  This case involves a 27 years old female patient who was 32 weeks pregnant and  was vaccinated with two doses (0.5 ml) of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot number U6272AA and expiration date 26-Apr-2021) inadvertently on 08-Oct-2019 and on 21-Oct-2019 via an intramuscular route in the right deltoid.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was unknown.  The gestation period was 32 weeks. The date of last menstrual period was 15-Mar-2019. The estimated due date is 14-Dec-2019. Information on previous pregnancy not reported. Medical history and concomitant medications were not reported.  It was a case of actual medication error due to extra dose administered.  Also this was a case of vaccine exposure during pregnancy.  At the time of reporting, no adverse reaction reported.  Additionally, at time of reporting, the pregnancy was still ongoing.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Tiny sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Tiny sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (Tiny sore arm). On 13-Apr-2021, PAIN IN EXTREMITY (Tiny sore arm) had resolved.            No concomitant medication were reported. No treatment information was provided by the reporter.
Night of injection pt developed a low grade fever of 101.0. By monday 4/19/21 patient had a rash on his arms and torso.  it then spread to his legs. Rash began as pink and very itch.  It has since become a darker pink and continues to itch.
mom reports constant crying 3 days p/vax was seen in ER on 4th day;
This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in her left arm on 16Mar2021 at 13:30(at the age of 43-years-old), as a single dose for COVID-19 immunization. The patient medical history included diabetic and latex allergy. The patient past drug history included lisinopril (MANUFACTURER UNKNOWN). Concomitant medications included januvia, metoprolol (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient had diagnosed with COVID-19. Since the vaccination patient had not been tested for COVID-19. The patient was allergic to latex and lisinopril. On 16Mar2021 at 15:30, the patient was ill for 2 full days, fever, nausea, chills, body aches and headache. The patient did not receive treatment for the reported events. The clinical outcome for illness, fever, nausea, chills, body aches, headache was recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.
A report was received from a health care professional on 30 October 2003, concerning an unspecified number of vaccines under 4 years of age who inadvertently received Fluvirin on an unspecified date.  On an unspecified date,an unspecified number of vaccines under 4 years of age inadvertently received Fluvirin.  No adverse effects had occurred at the time of report.  There was insufficient information to determine the reporter's causality assessment.  Updated 1, 01 December 2003.  Follow- up information received from a health care professional indicated that a 1 year old male vaccine inadvertently received Fluvirin on 18 October 2003 and had not experienced any adverse event at the time of the report.  No follow-up pending, all information received.
Patient developed localized myositis of the deltoid at the site of injection which became so severe that she has been unable to abduct her left arm above 90 degrees for the last 5 months. We are doing massage, physical therapy and iontophoresis and she is slowly improving, but may be permanently disabled.
pt recvd vax 5JUL95 & 16JUL95 pt exp generalized rash;no further details were provided;
This is a spontaneous report from a contactable physician via a sales representative. A patient of unspecified age, race and gender received TRUMENBA on an unspecified date at 0.5 ml single for immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever on an unspecified date with unknown outcome. The reporting physician considered the event related to the suspect vaccine.
Patient reports she experienced a firm red macular rash surrounding the injection site about 6 days after the inoculation. She denies pruritus at the site but endorses, the rash. Patient followed up with her PCP. I am unaware as to if the provider reported the reaction.